Dr. Ankit Ashwin Patel, MD

Dr. Patel practices at Mhs Physicians of Texas in Katy, Texas.

Dr. Patel's NPI, 1083979322, was assigned on July 12, 2012. Dr. Patel graduated from McGovern Medical School in 2009. Dr. Patel holds Texas license P6694.

Dr. Patel's primary practice is Mhs Physicians of Texas, at 507 Park Grove Ln, Katy, TX 77450 in Harris County. The practice phone is (713) 897-5900.

Dr. Patel's primary practice is Mhs Physicians of Texas in Katy, Texas. Dr. Patel is also affiliated with Memorial Hermann Katy Hospital. The medical group on file is UTHealth Houston Neurosciences, Texas Medical Center. Dmand AI also links Dr. Patel to 6 more hospitals, 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Patel is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Patel is licensed in Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Patel treats.

CMS data shows 733 Medicare services from Dr. Patel across 12 procedure codes in 2024, for 406 Medicare patients. Medicare paid $68,249 for them.

CMS counts 406 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 70, with 55% women.

In 2024, Dr. Patel wrote 2,243 Medicare Part D claims for 421 patients. 88% of them were for generic drugs. CMS names the drug for 1,999 of them, across 46 drugs with 11 or more claims each, at $335,876 in total drug cost. In 2023, CMS named 2,130 claims across 47 drugs.

Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Patel, published from 2014 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Machine Learning, Polycyclic Aromatic Hydrocarbons and Spectrum Analysis, Raman. Dr. Patel has published most often in Proc Natl Acad Sci U S A. Dr. Patel's most frequent co-authors are Sandhya Dhruvakumar, MD, Christine Marie Gerula, MD and Edo Kaluski, MD.

CMS Open Payments shows 1,598 general payments to Dr. Patel from 81 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $3,716.

Dr. Patel graduated from McGovern Medical School in 2009.

Dr. Patel is in network with 21 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.